News

Exscientia continues expansion with establishment of a subsidiary in Japan to target the pharmaceutical market across Asia

Submitted by karen.duncan on Tue, 03/26/2019 - 07:29

Exscientia, the world-leading Artificial Intelligence (AI)-driven drug discovery company announces the establishment of a subsidiary, Exscientia K.K to spearhead its pharmaceutical interests across

Dundee expert to feature in CBBC documentary

Submitted by karen.duncan on Mon, 03/25/2019 - 14:58

James Hutton Institute unveils international hub for water expertise

Submitted by karen.duncan on Fri, 03/22/2019 - 13:34

As part of Scotland’s continued efforts to become the world’s first Hydro Nation – one that manages its water environment to the best advantage and uses its expertise at home and internationally -

Celgene and Exscientia enter 3-year AI drug discovery collaboration focused on accelerating drug discovery in oncology and autoimmunity

Submitted by karen.duncan on Fri, 03/22/2019 - 13:14

Exscientia, a world-leading Artificial Intelligence (AI)-driven drug discovery company, announced today that it has entered a three-year AI drug discovery partnership with leading biopharma company